A predictive score for progression of COVID-19 in hospitalized persons : a cohort study
Accurate prediction of the risk of progression of coronavirus disease (COVID-19) is needed at the time of hospitalization. Logistic regression analyses are used to interrogate clinical and laboratory co-variates from every hospital admission from an area of 2 million people with sporadic cases. From a total of 98 subjects, 3 were severe COVID-19 on admission. From the remaining subjects, 24 developed severe/critical symptoms. The predictive model includes four co-variates: age (>60 years; odds ratio [OR] = 12 [2.3, 62]); blood oxygen saturation (<97%; OR = 10.4 [2.04, 53]); C-reactive protein (>5.75 mg/L; OR = 9.3 [1.5, 58]); and prothrombin time (>12.3 s; OR = 6.7 [1.1, 41]). Cutoff value is two factors, and the sensitivity and specificity are 96% and 78% respectively. The area under the receiver-operator characteristic curve is 0.937. This model is suitable in predicting which unselected newly hospitalized persons are at-risk to develop severe/critical COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
NPJ primary care respiratory medicine - 31(2021), 1 vom: 03. Juni, Seite 33 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xu, Jingbo [VerfasserIn] |
---|
Links: |
---|
Themen: |
9007-41-4 |
---|
Anmerkungen: |
Date Completed 15.06.2021 Date Revised 15.06.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41533-021-00244-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326318755 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326318755 | ||
003 | DE-627 | ||
005 | 20231225194332.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41533-021-00244-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1087.xml |
035 | |a (DE-627)NLM326318755 | ||
035 | |a (NLM)34083541 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xu, Jingbo |e verfasserin |4 aut | |
245 | 1 | 2 | |a A predictive score for progression of COVID-19 in hospitalized persons |b a cohort study |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.06.2021 | ||
500 | |a Date Revised 15.06.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Accurate prediction of the risk of progression of coronavirus disease (COVID-19) is needed at the time of hospitalization. Logistic regression analyses are used to interrogate clinical and laboratory co-variates from every hospital admission from an area of 2 million people with sporadic cases. From a total of 98 subjects, 3 were severe COVID-19 on admission. From the remaining subjects, 24 developed severe/critical symptoms. The predictive model includes four co-variates: age (>60 years; odds ratio [OR] = 12 [2.3, 62]); blood oxygen saturation (<97%; OR = 10.4 [2.04, 53]); C-reactive protein (>5.75 mg/L; OR = 9.3 [1.5, 58]); and prothrombin time (>12.3 s; OR = 6.7 [1.1, 41]). Cutoff value is two factors, and the sensitivity and specificity are 96% and 78% respectively. The area under the receiver-operator characteristic curve is 0.937. This model is suitable in predicting which unselected newly hospitalized persons are at-risk to develop severe/critical COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
650 | 7 | |a Oxygen |2 NLM | |
650 | 7 | |a S88TT14065 |2 NLM | |
700 | 1 | |a Wang, Weida |e verfasserin |4 aut | |
700 | 1 | |a Ye, Honghui |e verfasserin |4 aut | |
700 | 1 | |a Pang, Wenzheng |e verfasserin |4 aut | |
700 | 1 | |a Pang, Pengfei |e verfasserin |4 aut | |
700 | 1 | |a Tang, Meiwen |e verfasserin |4 aut | |
700 | 1 | |a Xie, Feng |e verfasserin |4 aut | |
700 | 1 | |a Li, Zhitao |e verfasserin |4 aut | |
700 | 1 | |a Li, Bixiang |e verfasserin |4 aut | |
700 | 1 | |a Liang, Anqi |e verfasserin |4 aut | |
700 | 1 | |a Zhuang, Juan |e verfasserin |4 aut | |
700 | 1 | |a Yang, Jing |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Chunyu |e verfasserin |4 aut | |
700 | 1 | |a Ren, Jiangnan |e verfasserin |4 aut | |
700 | 1 | |a Tian, Lin |e verfasserin |4 aut | |
700 | 1 | |a Li, Zhonghe |e verfasserin |4 aut | |
700 | 1 | |a Xia, Jinyu |e verfasserin |4 aut | |
700 | 1 | |a Gale, Robert P |e verfasserin |4 aut | |
700 | 1 | |a Shan, Hong |e verfasserin |4 aut | |
700 | 1 | |a Liang, Yang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t NPJ primary care respiratory medicine |d 2014 |g 31(2021), 1 vom: 03. Juni, Seite 33 |w (DE-627)NLM238372820 |x 2055-1010 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2021 |g number:1 |g day:03 |g month:06 |g pages:33 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41533-021-00244-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2021 |e 1 |b 03 |c 06 |h 33 |